Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease
Regadenoson is a widely used and well-tolerated vasodilator agent for pharmacologic stress myocardial perfusing imaging. In patients at higher risk of adverse reactions such as those with end stage renal disease, it can be reversed with early administration of aminophylline. However, little is known...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
| Series: | World Journal of Nuclear Medicine |
| Subjects: | |
| Online Access: | http://www.wjnm.org/article.asp?issn=1450-1147;year=2014;volume=13;issue=2;spage=142;epage=143;aulast=Abudiab |